LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

被引：0
|
作者：
Coghill, D. [1 ]
Hernandez Otero, I. [2 ]
Nagy, P. [3 ,4 ]
Soutullo, C. A. [5 ]
Zuddas, A. [6 ]
Geibel, B. [7 ]
Naser, N. [8 ]
Yan, B. [7 ]
Banaschewski, T. [9 ]
机构：
[1] Univ Dundee, Div Neurosci, Dundee, Scotland
[2] Maritime Hosp, Univ Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[3] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[4] Outpatient Clin, Budapest, Hungary
[5] Univ Navarra Clin, Dept Psychiat & Med Psychol, Child & Adolescent Psychiat Unit, Pamplona, Spain
[6] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy
[7] Shire, Wayne, PA USA
[8] Shire, Sydney, NSW, Australia
[9] Heidelberg Univ, Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Mannheim, Germany
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2016年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [31] Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder
    Gordon, Chanelle T.
    Fabiano, Gregory A.
    Hulme, Kevin F.
    Sodano, Sandro M.
    Adragna, Michael
    Lim, Rachel
    Stanford, Samantha
    Janikowski, Leah
    Bufalo, Bradley
    Rodriguez, Zulema
    Swiatek, Denise
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 29 (04) : 308 - 318
  • [32] Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity
    Ginsberg, Lawrence
    Katic, Alain
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Lasser, Robert
    Scheckner, Brian
    Adler, Lenard A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1097 - 1107
  • [33] European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Lyne, Andrew
    Squires, Liza
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1208 - 1218
  • [34] Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
    Childress, Ann
    Cutler, Andrew
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    Findling, Robert
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 533 - 533
  • [35] Update: Long-term safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder
    Bangs, ME
    Michelson, D
    Gao, H
    Feldman, P
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S273 - S273
  • [36] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    David R. Coghill
    Tobias Banaschewski
    Michel Lecendreux
    Alessandro Zuddas
    Ralf W. Dittmann
    Isabel Hernández Otero
    Richard Civil
    Ralph Bloomfield
    Liza A. Squires
    European Child & Adolescent Psychiatry, 2014, 23 : 61 - 68
  • [37] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Zuddas, Alessandro
    Dittmann, Ralf W.
    Otero, Isabel Hernandez
    Civil, Richard
    Bloomfield, Ralph
    Squires, Liza A.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (02) : 61 - 68
  • [38] COGNITIVE FUNCTION IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING LISDEXAMFETAMINE DIMESYLATE IN A 2-YEAR SAFETY STUDY
    Coghill, D.
    Banaschewski, T.
    Bliss, C.
    Robertson, B.
    Zuddas, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 106 - 107
  • [39] Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: Sex and age effects and effect size across the day
    Wigal S.B.
    Kollins S.H.
    Childress A.C.
    Adeyi B.
    Child and Adolescent Psychiatry and Mental Health, 4 (1)
  • [40] A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Lloyd, Eric
    Johnson, Steven A., Jr.
    Gunawardhana, Lhanoo
    Arnold, Valerie
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (02) : 98 - 106
12345